No Data
No Data
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Express News | INmune Bio Announced A Major Intellectual Property Milestone With Respect To Its Next-generation Mesenchymal Stromal Cell (MSC) Product, CORDStrom
INmune Bio Receives Favorable Patentability Opinion for CORDStrom Platform Technology
Express News | INmune Bio Partners With Cell and Gene Therapy Catapult to Scale up Cordstrom™ Manufacturing for Commercial Readiness
INmune Bio Partners With Cell and Gene Therapy Catapult to Scale Up CORDStrom Manufacturing for Commercial Readiness
BTIG Maintains INmune Bio(INMB.US) With Buy Rating, Maintains Target Price $21